BofA raised the firm’s price target on MetLife (MET) to $94 from $91 and keeps a Buy rating on the shares. Incorporating Q1 results into the firm’s model and updating projections, the firm’s forecasts rise from lower share count projections and higher earnings projections in Unum U.S., the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife’s Strategic Moves and Strong Group Benefits Performance Justify Buy Rating
- MetLife Reports Strong Q1 2025 Financial Results
- MetLife Announces $10 Billion Reinsurance Agreement
- MetLife reports Q1 adjusted EPS $1.96, consensus $2.00
- MetLife announces $10B variable annuity risk transfer transaction